ATE429500T1 - Stellenspezifischer einbau von ketoaminosäuren in proteine - Google Patents

Stellenspezifischer einbau von ketoaminosäuren in proteine

Info

Publication number
ATE429500T1
ATE429500T1 AT03809019T AT03809019T ATE429500T1 AT E429500 T1 ATE429500 T1 AT E429500T1 AT 03809019 T AT03809019 T AT 03809019T AT 03809019 T AT03809019 T AT 03809019T AT E429500 T1 ATE429500 T1 AT E429500T1
Authority
AT
Austria
Prior art keywords
proteins
site
orthogonal
methods
specific incorporation
Prior art date
Application number
AT03809019T
Other languages
English (en)
Inventor
Peter Schultz
Lei Wang
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE429500T1 publication Critical patent/ATE429500T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03809019T 2002-10-16 2003-10-15 Stellenspezifischer einbau von ketoaminosäuren in proteine ATE429500T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41926502P 2002-10-16 2002-10-16
US42099002P 2002-10-23 2002-10-23
PCT/US2003/032576 WO2004035743A2 (en) 2002-10-16 2003-10-15 Site specific incorporation of keto amino acids into proteins

Publications (1)

Publication Number Publication Date
ATE429500T1 true ATE429500T1 (de) 2009-05-15

Family

ID=32110229

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03809019T ATE429500T1 (de) 2002-10-16 2003-10-15 Stellenspezifischer einbau von ketoaminosäuren in proteine
AT09003609T ATE526414T1 (de) 2002-10-16 2003-10-15 Ortsspezifische einbindung von ketoaminosäuren in proteine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT09003609T ATE526414T1 (de) 2002-10-16 2003-10-15 Ortsspezifische einbindung von ketoaminosäuren in proteine

Country Status (16)

Country Link
US (5) US7432092B2 (de)
EP (2) EP1578949B1 (de)
JP (1) JP4444113B2 (de)
KR (1) KR20050072441A (de)
AT (2) ATE429500T1 (de)
AU (2) AU2003277373B2 (de)
CA (1) CA2502029C (de)
CY (1) CY1110483T1 (de)
DE (1) DE60327369D1 (de)
DK (1) DK1578949T3 (de)
ES (1) ES2324608T3 (de)
IL (3) IL167715A (de)
MX (1) MXPA05003983A (de)
PT (1) PT1578949E (de)
SI (1) SI1578949T1 (de)
WO (1) WO2004035743A2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158419A0 (en) * 2001-04-19 2004-05-12 Scripps Research Inst Methods and composition for the production of orthoganal trna-aminoacyl trna synthetase pairs
ES2333422T3 (es) * 2002-10-16 2010-02-22 The Scripps Research Institute Sintesis de glicoproteinas.
EP1613735B1 (de) 2003-04-17 2012-01-25 The Scripps Research Institute Ausweitung des eukaryotischen genetischen codes
EP2410331B1 (de) 2003-06-18 2015-09-23 The Scripps Research Institute Aminoacyl-tRNA Synthetase zur Aminoacylierung von tRNA mit unnatürlichen Aminosäuren
PT1914314E (pt) * 2003-07-07 2010-09-08 Scripps Research Inst Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações
US7527943B2 (en) 2003-07-07 2009-05-05 The Scripps Research Institute Compositions of orthogonal glutamyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
JP5657850B2 (ja) 2003-10-14 2015-01-21 ザ スクリプス リサーチ インスティテュート 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ
CA2553035A1 (en) 2004-02-02 2005-08-18 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
US7399619B2 (en) 2004-05-25 2008-07-15 The Scripps Research Institute Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
EP1771573A4 (de) 2004-07-21 2009-02-18 Ambrx Inc Nichtnatürliche kodierte aminosäuren verwendende biosynthetische polypeptide
EP2770053B1 (de) 2004-09-21 2018-02-21 The Scripps Research Institute In-vivo-Einbringung von Alkynyl-Aminosäuren in Proteine in Eubakterien
JP2008513806A (ja) * 2004-09-22 2008-05-01 ザ スクリップス リサーチ インスティテュート Nmr試験のための蛋白質の部位特異的標識
EP1809758A4 (de) 2004-10-20 2009-04-01 Scripps Research Inst Stellenspezifischer in-vivo-einbau von n-acetylgalactosamin-aminosäuren in eubakterien
US8216804B2 (en) 2004-10-27 2012-07-10 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
BRPI0518661A2 (pt) 2004-12-22 2008-12-02 Ambrx Inc mÉtodos para expressço e purificaÇço do hormânio do crescimento humano recombinante
SG158186A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CN102732588B (zh) 2004-12-22 2015-01-07 Ambrx公司 氨酰基-tRNA合成酶的组合物及其用途
BRPI0519170A8 (pt) 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
ATE542920T1 (de) 2004-12-22 2012-02-15 Ambrx Inc Modifiziertes menschliches wachstumshormon
WO2006133089A2 (en) 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
BRPI0617191A2 (pt) * 2005-10-12 2011-07-19 Scripps Research Inst modificação pós-traducional de polipeptìdeos expressos em fagos
CN101454461A (zh) 2005-11-16 2009-06-10 Ambrx公司 包括非天然氨基酸的方法和组合物
CA2882445A1 (en) 2005-12-14 2007-06-21 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
US7776535B2 (en) * 2006-02-06 2010-08-17 Franklin And Marshall College Site-specific incorporation of fluorinated amino acids into proteins
PL1991680T3 (pl) * 2006-03-09 2014-01-31 Scripps Research Inst Układ do ekspresji ortogonalnych składników translacji w eubakteryjnych komórkach gospodarza
MX2008011669A (es) * 2006-03-16 2008-09-22 Scripps Research Inst Expresion programada geneticamente de proteinas que contienen el aminoacido no natural fenilselenocisteina.
EP2018429A4 (de) * 2006-05-23 2010-07-14 Scrips Res Inst Genetisch kodierte fluoreszente cumarin-aminosäuren
WO2008030614A2 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Suppressor trna transcription in vertebrate cells
EP2615108B1 (de) 2006-09-08 2016-10-26 Ambrx, Inc. Modifiziertes humanes Plasmapolypeptid oder Fc-Gerüste und deren Verwendungen
US9133495B2 (en) * 2006-09-08 2015-09-15 Ambrx, Inc. Hybrid suppressor tRNA for vertebrate cells
MX2009002987A (es) 2006-09-21 2009-04-28 Scripps Research Inst Expresion geneticamente programada de proteinas selectivamente sulfatadas en eubacterias.
WO2008049034A1 (en) * 2006-10-17 2008-04-24 Zymera, Inc. System for assays of aminotranferase
JP2010506591A (ja) 2006-10-18 2010-03-04 ザ スクリップス リサーチ インスティテュート 哺乳動物細胞中の蛋白質への非天然アミノ酸の遺伝的組込み
GB0623974D0 (en) * 2006-11-30 2007-01-10 Medical Res Council Evolved orthogonal ribosomes
CN104163864B (zh) 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
WO2008137471A2 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
NZ600382A (en) 2008-07-23 2013-11-29 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
HUE035168T2 (en) 2008-09-26 2018-05-02 Ambrx Inc Modified animal erythropoietin polypeptides and their applications
EA201170493A1 (ru) 2008-09-26 2011-10-31 Амбркс, Инк. Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
WO2011073738A1 (en) 2009-12-14 2011-06-23 Metabolic Explorer Use of inducible promoters in the production of methionine
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
EP2805965A1 (de) 2009-12-21 2014-11-26 Ambrx, Inc. Modifizierte Schweine-Somatotropin-Polypeptide und deren Verwendungen
SI3572091T1 (sl) 2010-08-17 2024-07-31 Ambrx, Inc., Modificirani polipeptidi relaksina in njihova uporaba
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
CN102888387B (zh) * 2011-07-21 2015-03-18 中国科学院生物物理研究所 3-氯代酪氨酸翻译系统及其应用
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
WO2014165189A2 (en) 2013-03-13 2014-10-09 Eli Lilly And Company Modified canine leptin polypeptides
WO2015009948A1 (en) 2013-07-19 2015-01-22 Regents Of The University Of California Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
US10011649B2 (en) 2013-08-26 2018-07-03 Arizona Board Of Regents On Behalf Of Arizona State University High affinity synbodies for influenza
US10316322B2 (en) 2014-07-02 2019-06-11 Sutro Biopharma, Inc. High growth capacity auxotrophic Escherichia coli and methods of use
SMT202100388T1 (it) 2014-10-24 2021-09-14 Bristol Myers Squibb Co Polipeptidi fgf-21 modificati e loro usi
CN107406463A (zh) 2014-12-04 2017-11-28 细胞基因公司 生物分子共轭物
US9744624B2 (en) * 2015-06-17 2017-08-29 Kinsus Interconnect Technology Corp. Method for manufacturing circuit board
AU2017357785A1 (en) 2016-11-14 2019-04-11 Novartis Ag Methods and compositions for treatment of cartilage damage and arthritis
JP2020500020A (ja) 2016-11-14 2020-01-09 ノバルティス アーゲー 融合誘導性タンパク質minionに関連する組成物、方法、および治療上の使用
BR112019016139A2 (pt) 2017-02-08 2020-04-07 Bristol-Myers Squibb Company polipeptídio de relaxina modificada compreendendo um melhorador farmacocinético e usos do mesmo
TW202128996A (zh) * 2019-10-10 2021-08-01 美商史基普研究協會 用於活體內合成非天然多肽的組合物及方法
JP2025535713A (ja) 2022-10-07 2025-10-28 アンブレツクス・インコーポレイテツド 薬物リンカー及びその抗体コンジュゲート
WO2024091824A1 (en) 2022-10-26 2024-05-02 Ada Forsyth Institute, Inc. Differentiation and reprogramming of chondrocyte
EP4651906A1 (de) 2023-01-16 2025-11-26 Ambrx, Inc. Anti-cd70-antikörper-arzneimittelkonjugate
WO2024178310A1 (en) 2023-02-23 2024-08-29 Ambrx, Inc. Trop2-directed antibody-drug conjugates and uses thereof
WO2024241086A1 (en) 2023-05-24 2024-11-28 Ambrx, Inc. Pegylated bovine interferon lambda and methods of use thereof
WO2025041055A1 (en) 2023-08-22 2025-02-27 Ambrx, Inc. Anti-psma adc conjugate compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU723619B2 (en) 1995-04-24 2000-08-31 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
US5756316A (en) 1995-11-02 1998-05-26 Genencor International, Inc. Molecular cloning by multimerization of plasmids
US6238884B1 (en) 1995-12-07 2001-05-29 Diversa Corporation End selection in directed evolution
US5783431A (en) 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
IL158419A0 (en) * 2001-04-19 2004-05-12 Scripps Research Inst Methods and composition for the production of orthoganal trna-aminoacyl trna synthetase pairs
ES2333422T3 (es) * 2002-10-16 2010-02-22 The Scripps Research Institute Sintesis de glicoproteinas.

Also Published As

Publication number Publication date
JP4444113B2 (ja) 2010-03-31
EP2062976A3 (de) 2010-04-07
US20110318806A1 (en) 2011-12-29
IL167715A (en) 2010-11-30
US7432092B2 (en) 2008-10-07
ATE526414T1 (de) 2011-10-15
MXPA05003983A (es) 2005-06-22
HK1083351A1 (en) 2006-06-30
US20060068478A1 (en) 2006-03-30
EP2062976A2 (de) 2009-05-27
EP1578949A4 (de) 2006-12-20
IL201208A (en) 2011-02-28
PT1578949E (pt) 2009-07-14
US20090215117A1 (en) 2009-08-27
DE60327369D1 (de) 2009-06-04
KR20050072441A (ko) 2005-07-11
CY1110483T1 (el) 2015-04-29
US8114629B2 (en) 2012-02-14
WO2004035743A3 (en) 2005-11-10
DK1578949T3 (da) 2009-07-27
IL210359A0 (en) 2011-03-31
WO2004035743A2 (en) 2004-04-29
US20080227153A1 (en) 2008-09-18
AU2003277373B2 (en) 2009-05-07
WO2004035743A8 (en) 2005-06-09
SI1578949T1 (sl) 2009-08-31
EP1578949B1 (de) 2009-04-22
EP2062976B1 (de) 2011-09-28
US8071344B2 (en) 2011-12-06
AU2009203098A1 (en) 2009-08-20
ES2324608T3 (es) 2009-08-11
AU2003277373A1 (en) 2004-05-04
US7910345B2 (en) 2011-03-22
AU2009203098B2 (en) 2011-09-08
JP2006507814A (ja) 2006-03-09
US20080176284A1 (en) 2008-07-24
CA2502029C (en) 2014-06-10
US7524647B2 (en) 2009-04-28
EP1578949A2 (de) 2005-09-28
CA2502029A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
ATE429500T1 (de) Stellenspezifischer einbau von ketoaminosäuren in proteine
WO2005038002A3 (en) Site-specific incorporation of redox active amino acids into proteins
IL158419A (en) Cell containing orthogonal trna synthase (ors) and orthogonal trna (otrna)
ATE541934T1 (de) Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
EP1704242A4 (de) ZUSAMMENSETZUNGEN MIT PAAREN VON ORTHOGONALER LEUCYL-tRNA UND AMINOACYL-tRNA-SYNTHETASE UND VERWENDUNGEN DAVON
ATE386133T1 (de) Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen
WO2006034410A3 (en) Adding photoregulated amino acids to the genetic code
ATE542894T1 (de) Ausweitung des eukaryotischen genetischen codes
BRPI0411475A (pt) adições de código genético de aminoácido reativo não natural
MX2007003142A (es) Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
IL196893A0 (en) Site specific incorporation of non-natural amino acids by vertebrate cells
ATE352631T1 (de) Heterologe expression von neisseria proteine
ATE381623T1 (de) Verfahren zur expression von protein mit darin integrierter unnatürlicher aminosäure
EP1914314A3 (de) Zusammensetzungen aus orthogonalen Lysyl-TRNA- und Aminoacyl-TRNA-Synthetasepaaren und deren Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1578949

Country of ref document: EP